Publications
5674 Results
- Journal / Conference
- Lancet Oncology 13(7):734-742
- Year
- 2012
- Research Committee(s)
- Breast
- PMID
- PMID22704583
- PMC
- PMC4970583
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomized trial
- Journal / Conference
- PLoS ONE 7(11):e48787;
- Year
- 2012
- Research Committee(s)
- Melanoma
- PMID
- PMID23226204
- PMC
- PMC3511501
- Study Number(s)
- S0512
Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512
- Journal / Conference
- Journal of Clinical Oncology 30:(suppl 30; abstr 1); ASCO Markers in Cancer Annual Mtg, accepted, oral (Oct 11-13, 2012 Hollywood, FL);
- Year
- 2012
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0421
Circulating tumor cell (CTC) counts and CTC telomerase activity (TA) are prognostic of overall survival (OS) in SWOG S0421 - docetaxel with or without atrasentan for metastatic castration resistant prostate cancer (mCRPC)
- Journal / Conference
- Cancer Research 72(24 suppl):570S abst. OT2-2-04; San Antonio Breast Cancer Symposium, poster presentation - ongoing trials, (12/4-8/2012, San Antonio, TX);
- Year
- 2012
- Research Committee(s)
- Breast
- Study Number(s)
- S1207
A phase III randomized, placebo-controlled cllinical trial evaluating the use of adjuvant endocrine therapy +/- one year of everolimus in patients with high-risk, hormone receptor-(HR) positive and Her2-neu negative breast cancer: SWOG/NSABP S1207
- Journal / Conference
- Society of Integrative Oncology Annual Meeting (Oct 8-10, 2012, Albuquerque, NM), oral ;
- Year
- 2012
- Research Committee(s)
- Symptom Management and Survivorship
- Study Number(s)
- S1200
Methods for standardizing true and sham acupuncture in a multicenter randomized trial to reduce joint symptoms related to aromatase inhibitors in women with early stage breast cancer (SWOG 1200)
- Journal / Conference
- The Clinical Neuropsychologist 26(5):751-768
- Year
- 2012
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID22651854
- PMC
- PMC23064404
- Study Number(s)
- S0000A
Age expanded normative data for the Ruff 2 & 7 Selective Attention Test: evaluating cognition in older males
- Journal / Conference
- Blood 120(21):abst.3584; American Society of Hematology Annual Meeting, poster;
- Year
- 2012
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0703
A phase II trial of azacitidine (NSC-102816) and gemtuzumab ozogamicin (NSC0720568) as induction and post-remission therapy in patients of age 60 and older with previusly untreated non-M3 acute myeloid leukemia (SWOG S0703): Report on the poor risk patients
- Journal / Conference
- Blood 120(21):abst.2603; American Society of Hematology Annual Meeting, poster;
- Year
- 2012
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0910
SWOG study S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukemia
- Journal / Conference
- Blood 120(21):abst.2712; American Society of Hematology, poster;
- Year
- 2012
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0016, SWOG-8947, S9800, S9911
Low serum vitamin D levels are associated with inferior survival in follicular lymphoma: a prospective evaluation and replication in SWOG and LYSA
- Journal / Conference
- Blood 120(21):abst. 2590; American Society of Hematology Annual Meeting, poster;
- Year
- 2012
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106, SWOG-9031, SWOG-9333, SWOG-9500